Researchers welcome new multiple sclerosis drug

Courtesy EurekAlert! - Medicine and Health  Thu, 01/21/2010 - 23:00

(University of Rochester Medical Center) The Food and Drug Administration has approved the drug fampridine-SR for the treatment of multiple sclerosis.

Researchers at the University of Rochester Medical Center have been evaluating the effects of the drug in MS for more than 10 years -- it is the first medication shown to enhance some neurological functions in people with the disease -- and their efforts helped pave the way for today's action by the FDA.

Tags:

 

More related items

Starve a virus, feed a cure?
(University of Rochester Medical Center) A protein that protects some of our immune cells from the most common and virulent form of HIV works by starving the virus of the molecular building...

Scientists fixate on Ric-8 to understand trafficking...
(University of Rochester Medical Center) Half the drugs used today target a single class of proteins - and now scientists have identified an important molecular player critical to the proper...

US patent awarded for Rochester's pioneering HPV...
(University of Rochester Medical Center) The University of Rochester has been awarded a US patent for research essential to both human papillomavirus vaccines on the market. The patent is for...

The Unwritten Rules of Friendship: Simple Strategies...
"Nobody likes me!" is a complaint that parents hear all too often, and few utterances make them feel more helpless. Now help is at hand: This practical and compassionate guidebook enables...

Lobe Wonder Ear Support Patches For Earrings,...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com